Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03396497
Title Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Lycera Corp.
Indications

lung non-small cell carcinoma

Therapies

LYC-55716 + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST